Autres langues CURE BIOT OTC Markets

Actions

CUBT

US23128N2071

Marché Fermé - OTC Markets Autres places de cotation 21:33:43 20/05/2024			Varia. 5j.	Varia. 1 janv.
0,0181 ^USD	+41,96%		-25,51%	-15,02%

06/05	Curative Biotechnology, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	Curative Biotechnology, Inc. a retiré son introduction en bourse pour un montant de 7,999998 millions de dollars.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/05
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	22/03
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	08/01
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	25/11
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors	31/10/23
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	07/09/23
Curative Biotechnology, Inc. Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	07/06/23
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	06/06/23
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation	24/05/23
Curative Biotechnology, Inc. Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05/01/23
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05/01/23
Curative Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	16/11/22
Curative Biotechnology, Inc. has filed an IPO in the amount of $7.999998 million.	07/11/22
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $8 million.	31/10/22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27/09/22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27/09/22
Curative Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/09/22
Curative Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/06/22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16/06/22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CURE BIOT OTC Markets

Actions

CUBT

US23128N2071

Autres langues

Filtres